Detalles de la búsqueda
1.
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors.
BMC Urol
; 24(1): 96, 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38658905
2.
Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder.
Exp Mol Pathol
; 131: 104860, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36997051
3.
Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors.
Acta Oncol
; 62(12): 1880-1889, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37938166
4.
Nomograms including the UBC® Rapid test to detect primary bladder cancer based on a multicentre dataset.
BJU Int
; 130(6): 754-763, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34928524
5.
Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment.
Int J Mol Sci
; 23(14)2022 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35887247
6.
UBC® Rapid Test-A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-Study.
Int J Mol Sci
; 19(12)2018 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30513851
7.
UBC® Rapid Test for detection of carcinoma in situ for bladder cancer.
Tumour Biol
; 39(5): 1010428317701624, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28468590
8.
Presentation of a method at the Exploration Stage according to IDEAL: Percutaneous nephrolithotomy (PCNL) under local infiltrative anesthesia is a feasible and effective method - retrospective analysis of 439 patients.
Int J Med Sci
; 14(4): 302-309, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28553161
9.
Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Int J Mol Sci
; 17(11)2016 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27834929
10.
Evaluating the use of prostate-specific antigen as an instrument for early detection of prostate cancer beyond urologists: results of a representative cross-sectional questionnaire study of general practitioners and internal specialists.
Urol Int
; 93(2): 160-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24603136
11.
Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder.
Int Urol Nephrol
; 56(2): 499-508, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37777995
12.
CEA (CEACAM5) expression is common in muscle-invasive urothelial carcinoma of the bladder but unrelated to the disease course.
BJUI Compass
; 5(6): 585-592, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38873357
13.
Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer.
Eur Urol
; 86(1): 42-51, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38383257
14.
BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study.
Urol Oncol
; 41(12): 484.e17-484.e26, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37407421
15.
Loss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomas.
Front Oncol
; 13: 1342367, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38282671
16.
Luminophore Chemistry for Detection of Urinary Bladder Cancer - Comparison to Cytology and Urinary Rapid Tests (BTA stat®, NMP22® BladderChek® and UBC® Rapid Test).
Anticancer Res
; 42(11): 5249-5256, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36288849
17.
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder.
Hum Pathol
; 130: 10-17, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36152841
18.
Comparison of initial and second opinion reads of multiparametric magnetic resonance imaging of the prostate for transperineal template-guided biopsies with MRI-Ultrasound fusion.
Urol Oncol
; 39(11): 781.e1-781.e7, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33563540
19.
Identifying the Molecular Mechanisms Contributing to Progression, Metastasis, and Death in Low-grade Non-muscle-invasive Bladder Cancer: A Case Report.
Eur Urol Open Sci
; 27: 29-32, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34337514
20.
Health-related quality of life and rates of toxicity after high-dose-rate brachytherapy in combination with external beam radiation therapy for high-risk prostate cancer.
Investig Clin Urol
; 61(3): 250-259, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32377600